AI assistant
Ambu — Share Issue/Capital Change 2016
Nov 29, 2016
Preview isn't available for this file type.
Download source fileAt Ambu’s General Meeting on 12 December 2013, the Board of Directors were
authorised to issue warrants with a right to subscribe Class B shares for up to
a nominal amount of DKK 3,000,000 corresponding to 1,200,000 Class B shares of
DKK 2.50 in the company, without any pre-emption rights for the company’s
existing shareholders (Article 9d of the Articles of Association).
The Board of Directors has now decided to partly exercise the authorisation and
has thus issued and allocated 82,900 warrants with a right to the subscription
of 82,900 Class B shares in the company at a price of DKK 2.50. As a result of
this and previous allocations, the authorisation has been reduced to Class B
shares with a nominal value of DKK 1,407,750 corresponding to 563,100 shares of
DKK 2.50.
The allocation of 82,900 warrants is conditional upon Ambu achieving the
financial targets for the fiscal year 2016/17 as described on page 12 in the
annual report for 2015/16. The warrants are allocated in proportion to these
targets so that the warrants will be allocated in full by up to 10% negative
deviations from the target and proportionally in case of greater deviations.
The total number of 82,900 warrants are granted to 69 managers and selected
specialists for the purpose of employee retention. Ambu’s Executive Board does
not take part in this programme. The warrants allocated can be exercised by the
employees during a period starting three years after the date of allocation and
ending six years after the date of allocation. After this time, any warrants
which have not been exercised will lapse. The allocation is also conditional
upon continued employment.
The total value of the programme based on the Black-Scholes model is DKK 5.1m,
which will be expensed across the allocation period. The determination of the
Black-Scholes value is based on an assumed volatility of 29.8%, a dividend per
share of DKK 1.55 and a negative risk-free interest rate of 0.52% p.a. The
exercise price is determined as the average market price quoted on NASDAQ
Copenhagen during the period from 3 October 2016 and the following four trading
days plus 8%.
Contact
Lars Marcher, President & CEO, tel. +45 5136 2490, email: [email protected]
Ambu A/S
Baltorpbakken 13
DK-2750 Ballerup
Tel.: +45 7225 2000
CVR no.: 63 64 49 19
www.ambu.com